immunotherapy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
immunotherapy
May 1, 2024, 06:04 |
Insight
Martin Stumpe: Predicting MSI in prostate cancer from hematoxylin and eosin stained biopsy
Martin Stumpe, Chief of AI at Tempus, shared on LinkedIn: “We recently published a paper…
Apr 29, 2024, 15:35 |
Blog
Pashtoon Kasi: Time to revise assessment methods to reflect the pattern
Pashtoon Kasi shared a post on X: "Response assessment crudely telling regression % is missing the…
Apr 29, 2024, 15:30 |
Insight
Nicola Ferrari: Principles and therapeutic applications of adaptive immunity
Nicola Ferrari, Translational Science Lead at AstraZeneca, made the following post on LinkedIn: "Principles and…
Apr 28, 2024, 01:22 |
Blog
Patrick Hwu: Always great to catch up with our incredible founder Lee Moffitt
Patrick Hwu, President and CEO of Moffitt Cancer Center, shared on X: “Always great to catch…
Apr 26, 2024, 18:40 |
Blog
Dr. Carl June was awarded the 2024 Break through Prize in Life Sciences for the development of CART cell therapy - Penn Medicine, University of Pennsylvania Health System
Apr 24, 2024, 14:51 |
Blog
Jemma Arakelyan: Just completed the ESMO Advanced Course on lung cancer
Jemma Arakelyan, CEO at the Institute of Cancer and Crisis, shared a post on LinkedIn: "Just…
Apr 23, 2024, 20:22 |
Blog
Chandler Park: What a FUN precision medicine and immunotherapy meeting at Cleveland Clinic
Chandler Park, Kentucky Physician Representative of the ASCO State Executive Council, shared on LinkedIn: "What a…
Apr 23, 2024, 08:56 |
Blog
Naveen Pemmaraju: Appreciated the invitation to speak at MD Education meeting
Naveen Pemmaraju shared a post on X: "Appreciated the invitation to speak at MD Education meeting…
Apr 22, 2024, 20:02 |
Blog
Pashtoon Kasi: We underestimate how quickly immunotherapy works
Pashtoon Kasi, Director Colon Cancer Research and Director Precision Medicine Research for Liquid Biopsies at…
Apr 22, 2024, 18:48 |
Insight
Piotr Wysocki: Single-agent immunotherapy is a wise choice as first-line treatment in elderly, advanced NSCLC patients, irrespectively of PD-L1 expression
Piotr Wysocki, Professor of Medicine and Head of the Department of Oncology at Jagiellonian University…
2
3
4
5
6
All:
157
Posts:
31 - 40
OncoInfluencers: Dialogue with Rob Pieters, hosted by Shushan Hovsepyan
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Facebook
RSS Feed
Twitter
Linkedin
Youtube